In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study

Nanoparticles (NPs) are at the leading edge of nanomedicine, and determining their biosafety remains a mandatory precondition for biomedical applications. Herein, we explore the bioassimilation of copper sulfide NPs reported as powerful photo-responsive anticancer therapeutic agents. The nanoparticl...

Full description

Bibliographic Details
Main Authors: Alberto Curcio, Aurore Van de Walle, Christine Péchoux, Ali Abou-Hassan, Claire Wilhelm
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/1/179
_version_ 1797491107128410112
author Alberto Curcio
Aurore Van de Walle
Christine Péchoux
Ali Abou-Hassan
Claire Wilhelm
author_facet Alberto Curcio
Aurore Van de Walle
Christine Péchoux
Ali Abou-Hassan
Claire Wilhelm
author_sort Alberto Curcio
collection DOAJ
description Nanoparticles (NPs) are at the leading edge of nanomedicine, and determining their biosafety remains a mandatory precondition for biomedical applications. Herein, we explore the bioassimilation of copper sulfide NPs reported as powerful photo-responsive anticancer therapeutic agents. The nanoparticles investigated present a hollow shell morphology, that can be left empty (CuS NPs) or be filled with an iron oxide flower-like core (iron oxide@CuS NPs), and are compared with the iron oxide nanoparticles only (iron oxide NPs). CuS, iron oxide@CuS and iron oxide NPs were injected in 6-week-old mice, at doses coherent with an antitumoral treatment. Cu and Fe were quantified in the liver, spleen, kidneys, and lungs over 6 months, including the control animals, thus providing endogenous Cu and Fe levels in the first months after animal birth. After intravenous NPs administration, 77.0 ± 3.9% of the mass of Cu injected, and 78.6 ± 3.8% of the mass of Fe, were detected in the liver. In the spleen, we found 3.3 ± 0.6% of the injected Cu and 3.8 ± 0.6% for the Fe. No negative impact was observed on organ weight, nor on Cu or Fe homeostasis in the long term. The mass of the two metals returned to the control values within three months, a result that was confirmed by transmission electron microscopy and histology images. This bioassimilation with no negative impact comforts the possible translation of these nanomaterials into clinical practice.
first_indexed 2024-03-10T00:42:44Z
format Article
id doaj.art-e8e675a0228e46eda2c5d883cbf92418
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T00:42:44Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-e8e675a0228e46eda2c5d883cbf924182023-11-23T15:05:12ZengMDPI AGPharmaceutics1999-49232022-01-0114117910.3390/pharmaceutics14010179In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up StudyAlberto Curcio0Aurore Van de Walle1Christine Péchoux2Ali Abou-Hassan3Claire Wilhelm4Laboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, 75005 Paris, FranceLaboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, 75005 Paris, FranceINRAE, UMR 1313 GABI, MIMA2-Plateau de Microscopie Electronique, 78352 Jouy-en-Josas, FrancePHysico-Chimie des Electrolytes et Nanosystèmes InterfaciauX, PHENIX, CNRS, Sorbonne Université, 75005 Paris, FranceLaboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, 75005 Paris, FranceNanoparticles (NPs) are at the leading edge of nanomedicine, and determining their biosafety remains a mandatory precondition for biomedical applications. Herein, we explore the bioassimilation of copper sulfide NPs reported as powerful photo-responsive anticancer therapeutic agents. The nanoparticles investigated present a hollow shell morphology, that can be left empty (CuS NPs) or be filled with an iron oxide flower-like core (iron oxide@CuS NPs), and are compared with the iron oxide nanoparticles only (iron oxide NPs). CuS, iron oxide@CuS and iron oxide NPs were injected in 6-week-old mice, at doses coherent with an antitumoral treatment. Cu and Fe were quantified in the liver, spleen, kidneys, and lungs over 6 months, including the control animals, thus providing endogenous Cu and Fe levels in the first months after animal birth. After intravenous NPs administration, 77.0 ± 3.9% of the mass of Cu injected, and 78.6 ± 3.8% of the mass of Fe, were detected in the liver. In the spleen, we found 3.3 ± 0.6% of the injected Cu and 3.8 ± 0.6% for the Fe. No negative impact was observed on organ weight, nor on Cu or Fe homeostasis in the long term. The mass of the two metals returned to the control values within three months, a result that was confirmed by transmission electron microscopy and histology images. This bioassimilation with no negative impact comforts the possible translation of these nanomaterials into clinical practice.https://www.mdpi.com/1999-4923/14/1/179CuS nanoparticlesiron oxide nanoparticlesmagneto-plasmonic nanohybridsmetals bioassimilationlong-term biodistribution
spellingShingle Alberto Curcio
Aurore Van de Walle
Christine Péchoux
Ali Abou-Hassan
Claire Wilhelm
In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study
Pharmaceutics
CuS nanoparticles
iron oxide nanoparticles
magneto-plasmonic nanohybrids
metals bioassimilation
long-term biodistribution
title In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study
title_full In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study
title_fullStr In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study
title_full_unstemmed In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study
title_short In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study
title_sort in vivo assimilation of cus iron oxide and iron oxide cus nanoparticles in mice a 6 month follow up study
topic CuS nanoparticles
iron oxide nanoparticles
magneto-plasmonic nanohybrids
metals bioassimilation
long-term biodistribution
url https://www.mdpi.com/1999-4923/14/1/179
work_keys_str_mv AT albertocurcio invivoassimilationofcusironoxideandironoxidecusnanoparticlesinmicea6monthfollowupstudy
AT aurorevandewalle invivoassimilationofcusironoxideandironoxidecusnanoparticlesinmicea6monthfollowupstudy
AT christinepechoux invivoassimilationofcusironoxideandironoxidecusnanoparticlesinmicea6monthfollowupstudy
AT aliabouhassan invivoassimilationofcusironoxideandironoxidecusnanoparticlesinmicea6monthfollowupstudy
AT clairewilhelm invivoassimilationofcusironoxideandironoxidecusnanoparticlesinmicea6monthfollowupstudy